Triple-Negativity Identifies a Subgroup of Patients with Better Overall Survival in Essential Thrombocythemia

Triple-Negativity Identifies a Subgroup of Patients with Better Overall Survival in Essential Thrombocythemia

Essential thrombocythemia, as defined by the WHO in 2016, is a Philadelphia-negative chronic myeloproliferative neoplasm showing a better prognosis than polycythemia vera and myelofibrosis. In a variable percentage, patients with essential thrombocythemia show none of the known driver-gene mutations...

Full description

Bibliographic Details
Main Authors: Marco Santoro, Vincenzo Accurso, Salvatrice Mancuso, Mariasanta Napolitano, Marta Mattana, Giorgia Vajana, Federica Russello, Sergio Siragusa
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Hematology Reports
Subjects:
essential thrombocythemia
triple-negative
triple-negativity
survival
Online Access:https://www.mdpi.com/2038-8330/14/3/37

Internet

https://www.mdpi.com/2038-8330/14/3/37

Similar Items